Journal of Children's Orthopaedics

, Volume 7, Issue 3, pp 245–249

The effect of tranexamic acid in blood loss and transfusion volume in adolescent idiopathic scoliosis surgery: a single-surgeon experience

  • Marios G. Lykissas
  • Alvin H. Crawford
  • Gilbert Chan
  • Lori A. Aronson
  • Mohammed J. Al-Sayyad
Original Clinical Article



Intraoperative blood loss in scoliosis surgery often requires transfusions. Autogenous blood decreases but does not eliminate risks typically associated with allogenic blood transfusion. Costs associated with transfusions are significant. Tranexamic acid (TXA) has been shown to decrease blood loss in cardiac and joint surgery. Few studies have examined its use in pediatric spine surgery, and the results are inconsistent. The aim of this study was to determine whether TXA decreases intraoperative blood loss and transfusion requirements in adolescent idiopathic scoliosis patients undergoing posterior spinal fusion by a single surgeon.


The medical records and operative reports of surgically treated patients with adolescent idiopathic scoliosis between 2000 and 2009 were retrospectively reviewed. The inclusion criteria were: (1) patients who underwent instrumented posterior spinal fusion, (2) had complete medical records, and (3) were treated by the same surgeon. Forty-nine patients who met the inclusion criteria were divided into two groups: Group A (25 patients) received TXA, while Group B (24 patients) did not receive TXA.


After controlling for age at the time of surgery, gender, and number of vertebral levels fused, the mean intraoperative blood loss was significantly lower in Group A (537 ml) than in Group B (1,245 ml) (p = 0.027). The mean volume of blood transfused intraoperatively was 426 and 740 ml for Group A and Group B, respectively. The difference was not statistically significant after controlling for age, gender, and number of levels fused (p = 0.078).


TXA significantly decreased intraoperative blood loss in posterior spinal fusions performed for adolescent idiopathic scoliosis.


Adolescent idiopathic scoliosis Tranexamic acid Transfusion Spinal fusion 


  1. 1.
    Simpson MB, Georgopoulos G, Orsini E et al (1992) Autologous transfusions for orthopaedic procedures at a children’s hospital. J Bone Joint Surg Am 74:652–658Google Scholar
  2. 2.
    Meert KL, Kannan S, Mooney JF (2002) Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine 27:2137–2142CrossRefGoogle Scholar
  3. 3.
    Guay J, Haig M, Lortie L et al (1994) Predicting blood loss in surgery for idiopathic scoliosis. Can J Anaesth 41:775–781CrossRefGoogle Scholar
  4. 4.
    Shapiro F, Sethna N (2004) Blood loss in pediatric spine surgery. Eur Spine J 13:S6–S17CrossRefGoogle Scholar
  5. 5.
    Dodd RY (2007) Current risk for transfusion transmitted infections. Curr Opin Hematol 14:671–676Google Scholar
  6. 6.
    Tasaki T, Ohto H (2007) Nineteen years of experience with autotransfusion for elective surgery in children: more troublesome than we expected. Transfusion 47:1503–1509CrossRefGoogle Scholar
  7. 7.
    Popovsky MA, Whitaker B, Arnold NL (1995) Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 35:734–737CrossRefGoogle Scholar
  8. 8.
    Benavides S, Nicol K, Koranyi K et al (2003) Yersinia septic shock following an autologous transfusion in a pediatric patient. Transfus Apher Sci 28:19–23CrossRefGoogle Scholar
  9. 9.
    Sculco TP, Gallina J (1999) Blood management experience: relationship between autologous blood donation and transfusion in orthopedic surgery. Orthopedics 22:s129–s134Google Scholar
  10. 10.
    Triulzi DJ, Vanek K, Ryan DH et al (1992) A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 32:517–524CrossRefGoogle Scholar
  11. 11.
    Innerhofer P, Walleczek C, Luz G et al (1999) Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 39:625–632CrossRefGoogle Scholar
  12. 12.
    Innerhofer P, Klingler A, Klimmer C et al (2005) Risk for postoperative infection after transfusion of white blood cell-filtered allogeneic or autologous blood components in orthopedic patients undergoing primary arthroplasty. Transfusion 45:103–110CrossRefGoogle Scholar
  13. 13.
    Blumberg N (2005) Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 45:33S–40SCrossRefGoogle Scholar
  14. 14.
    Vamvakas EC (2002) Possible mechanisms of allogeneic blood transfusion-associated postoperative infection. Transfus Med Rev 16:144–160CrossRefGoogle Scholar
  15. 15.
    Blanchette CM, Wang PF, Joshi AV et al (2007) Cost and utilization of blood transfusion associated with spinal surgeries in the United States. Eur Spine J 16:353–363CrossRefGoogle Scholar
  16. 16.
    Dunn CJ, Goa KL (1999) Tranexamic acid: a review of its use in surgery and other indications. Drugs 57:1005–1032CrossRefGoogle Scholar
  17. 17.
    Longstaff C (1994) Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis 5:537–542Google Scholar
  18. 18.
    Wu CC, Ho WM, Cheng SB et al (2006) Perioperative parenteral tranexamic acid in liver tumor resection. A prospective randomized trial toward a “blood transfusion”-free hepatectomy. Ann Surg 243:173–180CrossRefGoogle Scholar
  19. 19.
    Mangano DT, Tudor IC, Dietzel C (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354:353–365CrossRefGoogle Scholar
  20. 20.
    Mangano DT, Miao Y, Vuylsteke A et al (2007) Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 297:471–479CrossRefGoogle Scholar
  21. 21.
    Yaniv E, Shvero J, Hadar T (2006) Hemostatic effect of tranexamic acid in elective nasal surgery. Am J Rhinol 20:227–229Google Scholar
  22. 22.
    Camarasa MA, Ollé G, Serra-Prat M et al (2006) Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 96:576–582CrossRefGoogle Scholar
  23. 23.
    Yamasaki S, Masuhara K, Fuji T (2005) Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. J Bone Joint Surg Am 87:766–770CrossRefGoogle Scholar
  24. 24.
    Benoni G, Fredin H (1996) Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 78:434–440Google Scholar
  25. 25.
    Phillips SJ, Chavan R, Porter ML et al (2006) Does salvage and tranexamic acid reduce the need for blood transfusion in revision hip surgery? J Bone Joint Surg Br 88:1141–1142CrossRefGoogle Scholar
  26. 26.
    Shapiro F, Zurakowski D, Sethna NF (2007) Tranexamic acid diminishes intraoperative blood loss and transfusion in spinal fusions for Duchenne muscular dystrophy scoliosis. Spine 32:2278–2283CrossRefGoogle Scholar
  27. 27.
    Sethna NF, Zurakowski D, Brustowicz RM et al (2005) Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 102:727–732CrossRefGoogle Scholar
  28. 28.
    Neilipovitz DT, Murto K, Hall L et al (2001) A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 93:82–87CrossRefGoogle Scholar
  29. 29.
    Grant JA, Howard J, Luntley J et al (2009) Perioperative blood transfusion requirements in pediatric scoliosis surgery: the efficacy of tranexamic acid. J Pediatr Orthop 29:300–304CrossRefGoogle Scholar
  30. 30.
    Neilipovitz DT (2004) Tranexamic acid for major spinal surgery. Eur Spine J 13:S62–S65CrossRefGoogle Scholar
  31. 31.
    Barrons RW, Jahr JS (1996) A review of post-cardiopulmonary bypass bleeding, aminocaproic acid, tranexamic acid, and aprotinin. Am J Ther 3:821–838CrossRefGoogle Scholar
  32. 32.
    Hardy JF, Desroches J (1992) Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 39:353–365CrossRefGoogle Scholar
  33. 33.
    Schneeweiss S, Seeger JD, Landon J et al (2008) Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 358:771–783CrossRefGoogle Scholar
  34. 34.
    Bess RS, Lenke LG (2006) Blood loss minimization and blood salvage techniques for complex spinal surgery. Neurosurg Clin N Am 17:227–234CrossRefGoogle Scholar
  35. 35.
    Kannan S, Meert KL, Mooney JF et al (2002) Bleeding and coagulation changes during spinal fusion surgery: a comparison of neuromuscular and idiopathic scoliosis patients. Pediatr Crit Care Med 3:364–369CrossRefGoogle Scholar
  36. 36.
    Ridgeway S, Tai C, Alton P et al (2003) Pre-donated autologous blood transfusion in scoliosis surgery. J Bone Joint Surg Br 85:1032–1036CrossRefGoogle Scholar
  37. 37.
    Zonis Z, Seear M, Reichert C et al (1996) The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 111:982–987CrossRefGoogle Scholar
  38. 38.
    Reid RW, Zimmerman AA, Laussen PC et al (1997) The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 84:990–996Google Scholar

Copyright information

© EPOS 2013

Authors and Affiliations

  • Marios G. Lykissas
    • 1
  • Alvin H. Crawford
    • 1
  • Gilbert Chan
    • 1
  • Lori A. Aronson
    • 1
  • Mohammed J. Al-Sayyad
    • 1
  1. 1.Division of Orthopaedic SurgeryCincinnati Children’s Hospital Medical Center, University of CincinnatiCincinnatiUSA

Personalised recommendations